CELL THERAPEUTICS INC
Cell Therapeutics, Inc. and Novuspharma S.p.A. sign merger agreement
Seattle, and Milan, Italy, June 17 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTIC) and Novuspharma S.p.A. (Novuspharma) (Nuovo Mercato: NOV.MI and NOV IM) management will host an investor conference call on Tues., June 17, 2003, at 2:30 p.m. Central European/1:30 p.m. United Kingdom/8:30 a.m. Eastern/5:30 a.m. Pacific to discuss the merger of the two biopharmaceutical companies. The conference call will be webcast live with presentation slides, and archived for viewing approximately two hours after the call ends.
A press conference call will also be hosted on Tues., June 17,
2003, at 7:45 p.m. Central European/6:45 p.m. United Kingdom/1:45 p.m.
Eastern/10:45
a.m. Pacific.
Investor Conference Call
Tues., June 17
2:30 p.m. Central European/1:30 p.m. United Kingdom/
8:30 a.m. Eastern/5:30 a.m. Pacific
1-800-967-7141 (US Participants)
+1-719-457-2630 (International)
Entry code: 424535
Live webcast with presentation slides at
www.cticseattle.com
Archived for post listening
approximately two hours after call ends
Call-back Numbers for Post Listening
1-888-203-1112 (US Participants)
+1-719-457-0820 (International)
Entry code: 424535
Press Conference Call
Tues., June 17
7:45 p.m. Central European/6:45 p.m. United Kingdom/
1:45 p.m. Eastern/10:45 a.m. Pacific
1-888-208-1812 (US Participants)
+1-719-457-2654 (International)
Entry code: 675493
For further information please contact:
Investors Media
Cell Therapeutics, Inc. Cell Therapeutics,
Inc.
Leah Grant Candice Douglass
T: +1 206.282.7100 T: +1 206.272.4472
F: +1 206.272.4010 F: +1 206.272.4010
E:
invest@ctiseattle.com E: media@ctiseattle.com
www.cticseattle.com/investors.htm www.cticseattle.com/media
.htm
In Europe
Novuspharma S.p.A.
Karl Hanks
T: +39 02 61035807
Mobile: +39 335 7882247
Silvano Spinelli
Tel: +39 02 61035700
www.novuspharma.com
Contact: investors, Leah Grant, +1-206-282-7100, or fax,
+1-206-272-4010,
or invest@ctiseattle.com, or media, or Candice Douglass,
+1-206-272-4472,
or fax, +1-206-272-4010, or media@ctiseattle.com, both of Cell
Therapeutics,
Inc.; or in Europe, Karl Hanks, +39-02-61035807, or mobile,
+39-335-7882247,
or Silvano Spinelli, +39-02-61035700, both of Novuspharma S.p.A.
Web site: http://www.novuspharma.com
Web site: http://www.cticseattle.com
(CTIC)
17 jun 03 08:39